Skip to content

China Biologic Products Holdings, Inc.: 10-Q filed 2014-08-05

What China Biologic Products Holdings, Inc. reported in its quarterly report filed 2014-08-05 (fiscal Q2 2014): 43 published measures, 122 facts as tagged in accession 0001144204-14-047094.

This filing

Form
10-Q (quarterly report)
Filed
2014-08-05
Fiscal period
fiscal Q2 2014
Accession
0001144204-14-047094 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All China Biologic Products Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-06-30449,453,333USD
At 2013-12-31403,781,207USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-06-30162,982,597USD
At 2013-12-3199,811,598USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-06-30207,815,530USD
At 2013-12-31237,691,563USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-06-30103,223,625USD
At 2013-12-31144,138,487USD
At 2013-06-30147,264,448USD
At 2012-12-31129,609,317USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-3019,724,955USD91
2014-01-01 to 2014-06-3037,998,626USD181
2013-04-01 to 2013-06-3016,161,926USD91
2013-01-01 to 2013-06-3031,077,786USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-06-3010,243,198USD181
2013-01-01 to 2013-06-3011,912,603USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-04-01 to 2014-06-3060,073,984USD91
2014-01-01 to 2014-06-30116,340,561USD181
2013-04-01 to 2013-06-3053,580,523USD91
2013-01-01 to 2013-06-30107,612,255USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-06-30211,743,177USD
At 2013-12-31173,744,551USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-04-01 to 2014-06-3023,483,090shares91
2014-01-01 to 2014-06-3024,212,766shares181
2013-04-01 to 2013-06-3026,880,459shares91
2013-01-01 to 2013-06-3026,833,262shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-04-01 to 2014-06-3024,719,011shares91
2014-01-01 to 2014-06-3025,435,122shares181
2013-04-01 to 2013-06-3028,067,303shares91
2013-01-01 to 2013-06-3027,967,080shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-04-01 to 2014-06-300.83USD/shares91
2014-01-01 to 2014-06-301.55USD/shares181
2013-04-01 to 2013-06-300.6USD/shares91
2013-01-01 to 2013-06-301.15USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-04-01 to 2014-06-300.79USD/shares91
2014-01-01 to 2014-06-301.47USD/shares181
2013-04-01 to 2013-06-300.57USD/shares91
2013-01-01 to 2013-06-301.11USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-04-01 to 2014-06-304,486,157USD91
2014-01-01 to 2014-06-309,824,375USD181
2013-04-01 to 2013-06-303,745,649USD91
2013-01-01 to 2013-06-308,352,551USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-06-3076,966,843USD
At 2013-12-3173,149,072USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-06-301,961,929USD181
2013-01-01 to 2013-06-303,047,962USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-04-01 to 2014-06-3028,873,235USD91
2014-01-01 to 2014-06-3056,851,968USD181
2013-04-01 to 2013-06-3025,315,313USD91
2013-01-01 to 2013-06-3051,293,705USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-06-30261,984,778USD
At 2013-12-31264,293,147USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-04-01 to 2014-06-30862,957USD91
2014-01-01 to 2014-06-301,484,164USD181
2013-04-01 to 2013-06-30198,739USD91
2013-01-01 to 2013-06-30434,913USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-06-3086,033,805USD
At 2013-12-3163,438,700USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-06-303,975,739USD
At 2013-12-314,445,732USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-06-3024,598,123USD
At 2013-12-3117,270,132USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-06-3094,812,741USD
At 2013-12-3188,634,855USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-04-01 to 2014-06-3041,154,003USD91
2014-01-01 to 2014-06-3079,705,414USD181
2013-04-01 to 2013-06-3037,458,261USD91
2013-01-01 to 2013-06-3074,873,235USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-04-01 to 2014-06-3018,919,981USD91
2014-01-01 to 2014-06-3036,635,147USD181
2013-04-01 to 2013-06-3016,122,262USD91
2013-01-01 to 2013-06-3032,739,020USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,838,795USD91
2014-01-01 to 2014-06-302,912,361USD181
2013-04-01 to 2013-06-30835,150USD91
2013-01-01 to 2013-06-301,748,242USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-06-3023,561,096shares
At 2013-12-3125,862,040shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-06-3076,267,027USD
At 2013-12-3172,031,864USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-06-3019,396,652USD
At 2013-12-3121,506,494USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2014-06-30286,470,736USD
At 2013-12-31303,969,609USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2014-06-30100,000,000USD
At 2013-12-3130,000,000USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-06-3091,912,722USD
At 2013-12-3176,775,260USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-06-3027,550,196USD
At 2013-12-3125,658,760USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-06-304,271,138USD
At 2013-12-312,585,232USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-06-304,041,464USD
At 2013-12-313,369,003USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2014-04-01 to 2014-06-3026,771,661USD91
2014-01-01 to 2014-06-3050,724,210USD181
2013-04-01 to 2013-06-3022,977,679USD91
2013-01-01 to 2013-06-3044,890,005USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-04-01 to 2014-06-3020,158,279USD91
2014-01-01 to 2014-06-3035,888,784USD181
2013-04-01 to 2013-06-3019,682,604USD91
2013-01-01 to 2013-06-3035,832,314USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-307,112,798USD91
2014-01-01 to 2014-06-3014,329,424USD181
2013-04-01 to 2013-06-308,866,071USD91
2013-01-01 to 2013-06-3017,553,168USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,817,138USD91
2014-01-01 to 2014-06-303,289,535USD181
2013-04-01 to 2013-06-301,571,232USD91
2013-01-01 to 2013-06-303,105,739USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-04-01 to 2014-06-302,384,583USD91
2014-01-01 to 2014-06-303,696,617USD181
2013-04-01 to 2013-06-301,408,015USD91
2013-01-01 to 2013-06-301,948,851USD181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2014-01-01 to 2014-06-301,154,991USD181
2013-01-01 to 2013-06-30720,679USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-307,473,499USD181
2013-01-01 to 2013-06-306,314,643USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-306,852,680USD181
2013-01-01 to 2013-06-303,616,165USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-438,427USD181
2013-01-01 to 2013-06-30242,365USD181

Inspect the source

Entity
China Biologic Products Holdings, Inc. / CIK 0001369868
Captured
SEC response SHA-256
b0858c70e7a3b91077c0e3df56721cd0deb1308061733593c5227aebcd4b73fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001369868.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))